BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND ELK4, SAP1, 2005, ENSG00000158711, P28324 AND Treatment
1062 results:

  • 1. The Albumin-bilirubin Grade as Prognostic Indicator for Recurrent Hepatocellular Carcinoma Needing Repeat liver Resection.
    Gon H; Komatsu S; Omiya S; Kido M; Fukushima K; Urade T; Yoshida T; Arai K; Ishida J; Nanno Y; Tsugawa D; Yanagimoto H; Toyama H; Fukumoto T
    Anticancer Res; 2024 May; 44(5):2031-2038. PubMed ID: 38677757
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Surgical treatment and prognosis analysis of hilar cholangiocarcinoma].
    Li XC; Li CX; Zhang H; Cheng F; Zhang F; Pu LY; Zhang CY; Wang K; Kong LB; Qian XF; Li DH; Lu WX; Wang P; Yao AH; Bai JF; Wu XF; Chen RX; Wang XH
    Zhonghua Wai Ke Za Zhi; 2024 Apr; 62(4):290-301. PubMed ID: 38432670
    [No Abstract]    [Full Text] [Related]  

  • 3. Accessibility to ERCP-performing hospitals among patients with pancreatic cancer living in SEER regions.
    Tavakkoli A; Beauchamp A; Prasad T; Zhu H; Singal AG; Elmunzer BJ; Kubiliun NM; Kwon RS; Hughes AE; Pruitt SL
    Cancer Med; 2024 Feb; 13(3):e7020. PubMed ID: 38400670
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical Impact of Conversion Surgery After Induction Therapy for Esophageal cancer with Synchronous Distant Metastasis: A Multi-institutional Retrospective Study.
    Sugimura K; Tanaka K; Sugase T; Momose K; Kanemura T; Yamashita K; Makino T; Shiraishi O; Motoori M; Yamasaki M; Miyata H; Fujitani K; Yasuda T; Yano M; Eguchi H; Doki Y
    Ann Surg Oncol; 2024 May; 31(5):3437-3447. PubMed ID: 38300405
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Impact of Hyperglycemia on Complication and Mortality after Transarterial Chemoembolization for Hepatocellular Carcinoma.
    Moon SJ; Ahn CH; Lee YB; Cho YM
    Diabetes Metab J; 2024 Mar; 48(2):302-311. PubMed ID: 38171144
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identifying optimal candidates for autologous peripheral blood stem cell therapy in patients with decompensated liver cirrhosis: a prognostic scoring system.
    Tian S; Guo G; Zhou X; Liu Y; Jia G; Zheng L; Cui L; Wang K; Zhang M; Sun K; Ma S; Yang C; Zhou X; Guo C; Shang Y; Han Y
    Stem Cell Res Ther; 2024 Jan; 15(1):8. PubMed ID: 38167085
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Significance of Ultra-Radical Surgery in Extensive Metastatic Ovarian Growing Teratoma Syndrome.
    Li S; Wang T; Du H; Tang H; Zhang T; Zhang R; Zhang X; Yang J
    Oncology; 2023; 101(12):773-781. PubMed ID: 38096801
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Reappraisal of Portal Vein Tumor Thrombosis as a Prognostic Factor for Patients with Hepatocellular Carcinoma.
    Chang Y; Yu SJ; Kim HC; Lee YB; Cho EJ; Lee JH; Kim YJ; Chung JW; Yoon JH
    Gut Liver; 2024 Jan; 18(1):156-164. PubMed ID: 38013475
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Epidemiology of HBV-HCV Coinfection Among Iranian Patients: a Systematic Review and Meta-Analysis.
    Anvari HZ; Binabaj MM; Asadi A; Abdi M; Shakiba A; Heidary M; Sholeh M
    Clin Lab; 2023 Nov; 69(11):. PubMed ID: 37948496
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Impact of multimorbidity and polypharmacy on mortality after cancer: a nationwide registry-based cohort study in Denmark 2005-2017.
    Thomsen MK; Løppenthin KB; Bidstrup PE; Andersen EW; Dalton S; Petersen LN; Pappot H; Mortensen CE; Christensen MB; Frølich A; Lassen U; Johansen C
    Acta Oncol; 2023 Dec; 62(12):1653-1660. PubMed ID: 37874076
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The adherence to the American Association for the Study of liver Diseases 2018 guidelines in the management of hepatocellular carcinoma and its impact on survival.
    Manne A; Mulekar M; Escobar D; Prodduturvar P; Fahmawi Y; Henderson P; Abdul-Rahim O; Hussain Z; Liles S; Fonseca A; Howard JH; Mneimneh W; Gilbert R; Alkharabsheh O; Pai S; White ZB; Nelson C; Khushman M
    J Cancer Res Ther; 2023; 19(5):1103-1108. PubMed ID: 37787270
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Cardiorespiratory fitness and BMI measured in youth and 5-year mortality after site-specific cancer diagnoses in men-A population-based cohort study with register linkage.
    Onerup A; Mehlig K; Ekblom-Bak E; Lissner L; Börjesson M; Åberg M
    Cancer Med; 2023 Oct; 12(19):20000-20014. PubMed ID: 37732468
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Radiofrequency ablation of subcapsular versus nonsubcapsular hepatocellular carcinomas ≤ 3 cm: analysis of long-term outcomes from two large-volume liver centers.
    Han K; Kim JH; Kim GH; Kim JH; Kim SY; Park SH; Moon S; Kwon JH; Kim GM; Lee SJ; Won HJ; Shin YM
    Eur Radiol; 2024 Mar; 34(3):1578-1586. PubMed ID: 37646813
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Disparities in treatment and survival in early-stage hepatocellular carcinoma in California.
    Gholami S; Kleber KT; Perry LM; Abidalhassan M; McFadden NR; Bateni SB; Maguire FB; Stewart SL; Morris C; Chen M; Gaskill CE; Merkow RP; Keegan TH
    J Surg Oncol; 2023 Dec; 128(8):1302-1311. PubMed ID: 37610042
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A surgical strategy for intrahepatic cholangiocarcinoma - the hilar first concept.
    Nevermann N; Bode J; Vischer M; Feldbrügge L; Knitter S; Krenzien F; Pelzer U; Fehrenbach U; Auer TA; Lurje G; Schmelzle M; Pratschke J; Schöning W
    Langenbecks Arch Surg; 2023 Aug; 408(1):296. PubMed ID: 37544932
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. External validation of subclassification system and progression pattern analysis in hepatocelluar carcinoma with macroscopic vascular invasion.
    Yu JI; Park HC; Shin H; Park H; Shin SW; Cho SK; Hyun D; Shin J; Goh MJ; Choi MS; Park B; Yoon SM; Jung J
    Radiother Oncol; 2023 Oct; 187():109841. PubMed ID: 37543052
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinical impact of hepatic steatosis on chronic hepatitis B patients in Asia: A systematic review and meta-analysis.
    Zhou R; Yang L; Zhang B; Gu Y; Kong T; Zhang W; Sun L; Liu C; Kong N; Li J; Shi J
    J Viral Hepat; 2023 Oct; 30(10):793-802. PubMed ID: 37533208
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Oncologic Significance of Therapeutic Delays in Patients With Oral Cavity cancer.
    Dayan GS; Bahig H; Johnson-Obaseki S; Eskander A; Hong X; Chandarana S; de Almeida JR; Nichols AC; Hier M; Belzile M; Gaudet M; Dort J; Matthews TW; Hart R; Goldstein DP; Yao CMKL; Hosni A; MacNeil D; Fowler J; Higgins K; Khalil C; Khoury M; Mlynarek AM; Morand G; Sultanem K; Maniakas A; Ayad T; Christopoulos A
    JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):961-969. PubMed ID: 37422839
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Multimodal treatment of rectal cancer with resectable synchronous liver metastases: A systematic review.
    Colletti G; Ciniselli CM; Sorrentino L; Bagatin C; Verderio P; Cosimelli M
    Dig Liver Dis; 2023 Dec; 55(12):1602-1610. PubMed ID: 37277288
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Correlation between recurrence-free survival and overall survival after upfront surgery for resected colorectal liver metastases.
    Kataoka K; Takahashi K; Takeuchi J; Ito K; Beppu N; Ceelen W; Kanemitsu Y; Ajioka Y; Endo I; Hasegawa K; Takahashi K; Ikeda M
    Br J Surg; 2023 Jun; 110(7):864-869. PubMed ID: 37196147
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 54.